These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2758329)

  • 1. Increased blood pressure induced by central application of aminopeptidase inhibitors is angiotensinergic-dependent in normotensive and hypertensive rat strains.
    Jensen LL; Harding JW; Wright JW
    Brain Res; 1989 Jun; 490(1):48-55. PubMed ID: 2758329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressor responses to amastatin, bestatin and Plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran.
    Batt CM; Klein EW; Harding JW; Wright JW
    Brain Res Bull; 1988 Nov; 21(5):731-5. PubMed ID: 3219604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
    Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW
    Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminopeptidase-induced elevations and reductions in blood pressure in the spontaneously hypertensive rat.
    Wright JW; Mizutani S; Murray CE; Amir HZ; Harding JW
    J Hypertens; 1990 Oct; 8(10):969-74. PubMed ID: 2174951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of aminopeptidase inhibitors on angiotensin-induced pressor responses.
    Sullivan MJ; Harding JW; Wright JW
    Brain Res; 1988 Jul; 456(2):249-53. PubMed ID: 3208081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central effects of a specific angiotensin receptor antagonist, sarthran (Sar1, Thr8AII) in normotensive and spontaneously hypertensive rat strains.
    Jensen LL; Harding JW; Wright JW
    Brain Res; 1988 May; 448(2):359-63. PubMed ID: 3378158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunction of central angiotensinergic aminopeptidase activity in spontaneously hypertensive rats.
    Wright JW; Sullivan MJ; Harding JW
    Neurosci Lett; 1985 Nov; 61(3):351-6. PubMed ID: 3001599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucine aminopeptidase M-induced reductions in blood pressure in spontaneously hypertensive rats.
    Wright JW; Jensen LL; Cushing LL; Harding JW
    Hypertension; 1989 Jun; 13(6 Pt 2):910-5. PubMed ID: 2737729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
    Abhold RH; Sullivan MJ; Wright JW; Harding JW
    J Pharmacol Exp Ther; 1987 Sep; 242(3):957-62. PubMed ID: 3656120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amastatin and bestatin-induced dipsogenicity in the Sprague-Dawley rat.
    Quirk WS; Harding JW; Wright JW
    Brain Res Bull; 1987 Jul; 19(1):145-7. PubMed ID: 3651838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heightened pressor effect and dipsogenicity to intracerebroventricularly applied angiotensin II and III in spontaneously hypertensive rats.
    Wright JW; Sullivan MJ; Quirk WS; Batt CM; Harding JW
    J Hypertens Suppl; 1986 Dec; 4(6):S408-11. PubMed ID: 3475426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heightened blood pressure and drinking responsiveness to intracerebroventricularly applied angiotensins in the spontaneously hypertensive rat.
    Wright JW; Sullivan MJ; Quirk WS; Batt CM; Harding JW
    Brain Res; 1987 Sep; 420(2):289-94. PubMed ID: 3676761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aminopeptidase inhibition on the half-lives of [125I]angiotensins in the cerebroventricles of the rat.
    Dewey AL; Wright JW; Hanesworth JM; Harding JW
    Brain Res; 1988 May; 448(2):369-72. PubMed ID: 3378160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotensive effects of sarthran in normotensive and spontaneously hypertensive rat strains.
    Murray CE; Harding JW; Wright JW
    Pharmacol Biochem Behav; 1991 Aug; 39(4):1029-32. PubMed ID: 1763099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypothalamic-angiotensin system: location and functional considerations.
    Felix D; Harding JW; Imboden H
    Clin Exp Hypertens A; 1988; 10 Suppl 1():45-62. PubMed ID: 3243007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA and bicuculline-induced blood pressure changes in spontaneously hypertensive rats.
    Roberts KA; Wright JW; Harding JW
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):156-62. PubMed ID: 7678672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of aminopeptidase inhibitors on brain angiotensin metabolism and drinking in rats.
    Wright JW; Quirk WS; Hanesworth JM; Harding JW
    Brain Res; 1988 Feb; 441(1-2):215-20. PubMed ID: 3359232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of aminopeptidase M as a hypotensive agent in spontaneously hypertensive rats.
    Wright JW; Amir HZ; Murray CE; Roberts KA; Harding JW; Mizutani S; Ward PE
    Brain Res Bull; 1991 Nov; 27(5):545-51. PubMed ID: 1684525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the aminopeptidase inhibitors amastatin and bestatin on angiotensin-evoked neuronal activity in rat brain.
    Harding JW; Felix D
    Brain Res; 1987 Oct; 424(2):299-304. PubMed ID: 3676828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of aminopeptidase A in hypertension in spontaneously hypertensive rats (SHRs) and change of refractoriness in response to angiotensin II in pregnant SHRs.
    Nakashima Y; Ohno Y; Itakura A; Takeuchi M; Murata Y; Kuno N; Mizutani S
    J Hypertens; 2002 Nov; 20(11):2233-8. PubMed ID: 12409962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.